Publicación: Candidemia and antifungal susceptibility in Peruvian hospitals
| dc.contributor.author | Rios-Blanco, Romina | |
| dc.contributor.author | Olsen-Verme, Marcello | |
| dc.contributor.author | Palomino, Fiorella | |
| dc.contributor.author | Ludowieg, Michelle Regal | |
| dc.contributor.author | Jacobs, Jan | |
| dc.contributor.author | Krapp, Fiorella | |
| dc.contributor.author | Bustamante, Beatriz | |
| dc.contributor.author | Garcia, Coralith | |
| dc.date.accessioned | 2026-05-01T06:27:01Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Worldwide, Candida bloodstream infections have presented an increase in non-albicans Candida species and resistance to antifungal agents. Objective: To describe the microbiological characteristics of consecutive Candida blood culture isolates. Methods: This study analyzed 73 consecutive Candida blood isolates recovered between July 2017 and July 2019 from routine patient care at 15 Peruvian hospitals, assessing susceptibility to four antifungal agents. Results: The species most frequently detected were Candida parapsilosis 39 (53.4%), Candida albicans 23 (31.5%), and Candida tropicalis 5 (6.8%). Conclusions: All isolates were susceptible to amphotericin B, fluconazole, voriconazole, and anidulafungin. There is a predominance of non-albicans Candida cases in Peru and a high susceptibility to current antifungal drugs. © Revista Médica Herediana. | en_US |
| dc.description.sponsorship | Funding text 1: The Belgian Directorate of Development Cooperation and Humanitarian Aid (DGD), through the Institute of Tropical Medicine Antwerp supported this work (Framework Agreement 4). The authors declare that they; Funding text 2: We extend our gratitude to the Clinical Mycology Laboratory of IMT AvH staff, Mg. Edgar Neyra, for developing the molecular analysis, and all the collaborators from the hospitals that participated in the study. | es_PE |
| dc.identifier.doi | https://doi.org/10.20453/rmh.v36i2.6233 | |
| dc.identifier.scopus | 2-s2.0-105010734320 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12866/19502 | |
| dc.language.iso | eng | |
| dc.publisher | Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado | |
| dc.relation.ispartof | urn:issn:1018-130X | |
| dc.relation.ispartofseries | Revista Medica Herediana | |
| dc.relation.issn | 1018-130X | |
| dc.rights | http://purl.org/coar/access_right/c_abf2 | |
| dc.subject | Antifungal agents | en_US |
| dc.subject | Antifungal Drug Resistance | en_US |
| dc.subject | Candida | en_US |
| dc.subject | Candidemia | en_US |
| dc.title | Candidemia and antifungal susceptibility in Peruvian hospitals | en_US |
| dc.title | Candidemia y susceptibilidad a antifúngicos en hospitales peruanos | es_PE |
| dc.type | https://purl.org/coar/resource_type/c_2df8fbb1 | |
| dc.type.local | Artículo de revista | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dspace.entity.type | Publication |
